Industry Research Reports

The global Hormonal Supplements revenue was US$ 360 million in 2023 and is forecast to a readjusted size of US$ 597 million by 2030 with a CAGR of 7.5% during the review period (2024-2030).

The global market for Hormonal Supplements was estimated to be worth US$ 360 million in 2023 and is forecast to a readjusted size of US$ 597 million by 2030 with a CAGR of 7.5% during the forecast period 2024-2030.

The global market for Hormonal Supplements was valued at US$ 360 million in the year 2023 and is projected to reach a revised size of US$ 597 million by 2030, growing at a CAGR of 7.5% during the forecast period.

Valued at US$ 387 million in 2024, the global Hormonal Supplements market is forecast to reach US$ 597 million by 2030, at a CAGR of 7.5% during the forecast period.

The global market for Non-Adhesive Liquid Embolic Agents was estimated to be worth US$ 133 million in 2023 and is forecast to a readjusted size of US$ 222 million by 2030 with a CAGR of 7.6% during the forecast period 2024-2030.

The global Non-Adhesive Liquid Embolic Agents revenue was US$ 133 million in 2023 and is forecast to a readjusted size of US$ 222 million by 2030 with a CAGR of 7.6% during the review period (2024-2030).

The global market for Medical Liquid Embolic Agents was estimated to be worth US$ 133 million in 2023 and is forecast to a readjusted size of US$ 222 million by 2030 with a CAGR of 7.6% during the forecast period 2024-2030.

Valued at US$ 143 million in 2024, the global Non-Adhesive Liquid Embolic Agents market is forecast to reach US$ 222 million by 2030, at a CAGR of 7.6% during the forecast period.

The global market for Medical Liquid Embolic Agents was valued at US$ 133 million in the year 2023 and is projected to reach a revised size of US$ 222 million by 2030, growing at a CAGR of 7.6% during the forecast period.

Valued at US$ 143 million in 2024, the global Medical Liquid Embolic Agents market is forecast to reach US$ 222 million by 2030, at a CAGR of 7.6% during the forecast period.